Biology of Blood and Marrow Transplantation
Volume 15, Issue 10 , Pages 1265-1270 , October 2009

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Low Left Ventricular Ejection Fraction

  • Muzaffar H. Qazilbash

      Affiliations

    • Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • Corresponding Author InformationCorrespondence and reprint requests: Muzaffar H. Qazilbash, MD, Department of Stem Cell Transplantation and Cellular Therapy—423, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030.
    • ,
  • Ali Imran Amjad

      Affiliations

    • Department of Internal Medicine, University of Pittsburgh, Pennsylvania
    • ,
  • Suhail Qureshi

      Affiliations

    • Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Sofia R. Qureshi

      Affiliations

    • Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Rima M. Saliba

      Affiliations

    • Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Ziad U. Khan

      Affiliations

    • Department of Internal Medicine, University of Texas at Houston, Houston, Texas
    • ,
  • Chitra Hosing

      Affiliations

    • Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Sergio A. Giralt

      Affiliations

    • Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Marcos J. De Lima

      Affiliations

    • Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Uday R. Popat

      Affiliations

    • Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Syed W. Yusuf

      Affiliations

    • Department of Cardiology, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Richard E. Champlin

      Affiliations

    • Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas

Received 9 March 2009 ,Accepted 3 June 2009.

References 

  1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354:1813–1826
  2. Bearman SI, Petersen FB, Schor RA, et al. Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity. Bone Marrow Transplant. 1990;5:173–177
  3. Fujimaki K, Maruta A, Yoshida M, et al. Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction. Bone Marrow Transplant. 2001;27:307–310
  4. Sakata-Yanagimoto M, Kanda Y, Nakagawa M, et al. Predictors for severe cardiac complications after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2004;33:1043–1047
  5. Tichelli A, Bhatia S, Socie G. Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation. Br J Haematol. 2008;142:11–26
  6. Yoshimi A, Nannya Y, Sakata-Yanagimoto M, et al. A myeloablative conditioning regimen for patients with impaired cardiac function undergoing allogeneic stem cell transplantation: reduced cyclophosphamide combined with etoposide and total body irradiation. Am J Hematol. 2008;83:635–639
  7. Gopal AS, Shen Z, Sapin PM, et al. Assessment of cardiac function by three-dimensional echocardiography compared with conventional noninvasive methods. Circulation. 1995;92:842–853
  8. Common Terminology Criteria for Adverse Events, Version 3.0 (CTCAE v3.0). DCTD, NCI, NIH, DHHS, 2006.
  9. Akahori M, Nakamae H, Hino M, et al. Electrocardiogram is very useful for predicting acute heart failure following myeloablative chemotherapy with hematopoietic stem cell transplantation rescue. Bone Marrow Transplant. 2003;31:585–590
  10. Zangari M, Henzlova MJ, Ahmad S, et al. Predictive value of left ventricular ejection fraction in stem cell transplantation. Bone Marrow Transplant. 1999;23:917–920
  11. Cazin B, Gorin NC, Laporte JP, et al. Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations. Cancer. 1986;57:2061–2069
  12. Hertenstein B, Stefanic M, Schmeiser T, et al. Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant. J Clin Oncol. 1994;12:998–1004
  13. Kupari M, Volin L, Suokas A, Timonen T, Hekali P, Ruutu T. Cardiac involvement in bone marrow transplantation: electrocardiographic changes, arrhythmias, heart failure and autopsy findings. Bone Marrow Transplant. 1990;5:91–98
  14. Murdych T, Weisdorf DJ. Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997. Bone Marrow Transplant. 2001;28:283–287
  15. Sucak GT, Ozkurt ZN, Aki Z, Yagci M, Cengel A, Haznedar R. Cardiac systolic function in patients receiving hematopoetic stem cell transplantation: risk factors for posttransplantation cardiac toxicity. Transplant Proc. 2008;40:1586–1590
  16. Buja LM, Ferrans VJ, Graw RG. Cardiac pathologic findings in patients treated with bone marrow transplantation. Hum Pathol. 1976;7:17–45
  17. Trigg ME, Finlay JL, Bozdech M, Gilbert E. Fatal cardiac toxicity in bone marrow transplant patients receiving cytosine arabinoside, cyclophosphamide, and total body irradiation. Cancer. 1987;59:38–42
  18. Baello EB, Ensberg ME, Ferguson DW, et al. Effect of high-dose cyclophosphamide and total-body irradiation on left ventricular function in adult patients with leukemia undergoing allogeneic bone marrow transplantation. Cancer Treat Rep. 1986;70:1187–1193
  19. Benoff LJ, Schweitzer P. Radiation therapy-induced cardiac injury. Am Heart J. 1995;129:1193–1196
  20. Braverman AC, Antin JH, Plappert MT, Cook EF, Lee RT. Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. J Clin Oncol. 1991;9:1215–1223
  21. Coghlan JG, Handler CE, Kottaridis PD. Cardiac assessment of patients for haematopoietic stem cell transplantation. Best Pract Res Clin Haematol. 2007;20:247–263
  22. Lopez-Jimenez J, Cervero C, Munoz A, et al. Cardiovascular toxicities related to the infusion of cryopreserved grafts: results of a controlled study. Bone Marrow Transplant. 1994;13:789–793
  23. Shan K, Lincoff AM, Young JB. Anthracycline-induced cardiotoxicity. Ann Intern Med. 1996;125:47–58
  24. Sorror ML, Giralt S, Sandmaier BM, et al. Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences. Blood. 2007;110:4606–4613
  25. Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106:2912–2919

 Financial disclosure: See Acknowledgments on page 1269.

PII: S1083-8791(09)00274-2

doi: 10.1016/j.bbmt.2009.06.001

Biology of Blood and Marrow Transplantation
Volume 15, Issue 10 , Pages 1265-1270 , October 2009

Article Tools

* Image Usage & Resolution